Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07700108Phase 3Recruiting
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in trypanophobia, sponsored by The Ohio State University. Started Oct 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07700108.